Health Dictionary Find a Doctor

Epilepsy

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Epilepsy is a common chronic neurological disorder that is characterized by recurrent unprovoked seizures. These seizures are transient signs and/or symptoms due to abnormal, excessive or synchronous neuronal activity in the brain. About 50 million people worldwide have epilepsy at any one time. Epilepsy is usually controlled, but not cured, with medication, although surgery may be considered in difficult cases. Not all epilepsy syndromes are lifelong – some forms are confined to particular stages of childhood. Epilepsy should not be understood as a single disorder, but rather as a group of syndromes with vastly divergent symptoms but all involving episodic abnormal electrical activity in the brain.

Historical Perspective

The word epilepsy is derived from the Greek epilepsia, which in turn can be broken in to epi- (upon) and lepsis (to take hold of, or seizure). In the past, epilepsy was associated with religious experiences and even demonic possession. Claudius Galen was the first person who described epilepsy as a brain disease. Boerhaave was the first person who differentiate petit mal epilepsy, grand mal epilepsy and hysteria. Marshall Hall described reflex theory in which paroxysmal nervous discharges are responsible for epilepsy seizures. The very first evidence of epilepsy treatment goes back to 10,000 years ago when making holes in skull bones was done in order to treat epilepsy. In the past three decades anti-epileptic drugs are used widely for symptomatic control of epileptic patients.

Classification

Epilepsy may be classified according to type of onset into focal, generalized and unknown. Each of these groups can be further divided into motor and non-motor subgroups.

Pathophysiology

It is understood that epileptic seizure is the result of uncontrolled unusual synchronized, localized or widely distributed neuronal electrical discharges. The underlying event in all types of seizures is the paroxysmal depolarization shift (PDS) which also causes the EEG changes. In a normal circumstance we have a refractory period after every action potential, but in PDS, the absence of refractory period causes a prolonged membrane depolarization. In order to cause a seizure, so many PDSs most happen in the same time. Any alternation in a synaptic characteristics such as amount of neurotransmitters, function of inhibitory neurons, function of excitatory neurons, synaptic structure and ion channels involved in neurotransmitter release and conduction of action potential can prone a person to epilepsy. In focal epilepsy, epileptiform activity starts in a specific area of brain. It can further spread and cause secondary generalized seizure. In generalized epilepsy seizures occur in both cerebral hemispheres simultaneously or spread so fast from one to another that in EEG, we can see bilateral epileptiform activity from the start.

Causes

Common causes of epilepsy include head trauma, brain tumor, brain hemorrhage, encephalitis, hypoglycemia, hypoxic encephalopathy, stroke, cerebral palsy, electrolyte disturbances, epileptic encephalopathy – Lennox-Gastaut type, febrile seizures, Huntington’s disease, intoxication and uremia.

Differentiating epilepsy from other diseases

Epilepsy must be differentiated from psychogenic nonepileptic attacks (PNEAs), syncope, hypoglycemia, panic attacks, acute dystonic reactions, hemifacial spasm, nonepileptic myoclonus, parasomnias, cataplexy, hypnic jerks, transient ischemic attacks, migraines and transient global amnesia.

Epidemiology and Demographics

Epilepsy’s approximate annual incidence rate is 40–70 per 100,000 in industrialized countries and 100–190 per 100,000 in resource-poor countries; socioeconomically deprived people are at higher risk. The prevalence of active epilepsy is roughly in the range 5–10 per 1000 people. Many studies have demonstrated that mortality rate is higher in people with epilepsy. The most common causes of death in these patients are trauma, pneumonia, suicide, status epilepticus and sudden unexpected death. Epilepsy is one of the most common of the serious neurological disorders. Genetic, congenital, and developmental conditions are mostly associated with it among younger patients; tumors are more likely over age 40; head trauma and central nervous system infections may occur at any age. There is no evidence of race differences in incidence and prevalence of epilepsy. It was demonstrated that nonsymptomatic epilepsy such as cryptogenic localization-related and idiopathic generalized epilepsy are more common in women while symptomatic localization-related epilepsy is more common in men.

Risk Factors

Common triggers of seizure include sleep deprivation, fever, light flashing, hyperventilation, alcohol, physical stress such as physical exercise or illness, psychological stress, depression.

Screening

There is insufficient evidence to recommend routine screening for epilepsy.

Natural History, Complications and Prognosis

If left untreated, 23% to 71% of patients with a single unprovoked seizure may experience it again within 2 years. After the second unprovoked seizure, the chance of having another seizure increase to 73%. Recurrent seizures with no underlying illness emphasis on epilepsy diagnosis. Common complications of epilepsy include status epilepticus, sudden unexpected death, submersion Injury, dental injury, burns, fractures, head injury, soft tissue injury and motor vehicle accidents.

Diagnosis

Diagnostic Study of Choice

There is no single diagnostic study of choice for the diagnosis of epilepsy, but epilepsy can be diagnosed based on history, symptoms and physical examination of a patient with seizure complain. Among the patients who present with clinical signs of seizure, the EEG is the most efficient test for diagnosis. Video-EEG monitoring is a combination of recording EEG and clinical behavior of the patient. Although it’s more expensive, it is more effective in differentiating different type if seizures. With the first seizure, we should perform laboratory study ( electrolytes, glucose, calcium, magnesium, complete blood count, renal function tests, liver function tests, urinalysis, toxicology screens), imaging study ( MRI, CT Scan), EEG, video-EEG monitoring and lumbar puncture.

History and Symptoms

A positive history of family member with epilepsy, brain traumatic injuries, meningitis and encephalitis, febrile seizure in the childhood, enuresis, drug abuse and previous episod of seizure is suggestive of epilepsy. The most common symptoms of epileptic seizure include paroxysmal manner, similarity to each other in a patient in the aspect of duration and general characteristics, presenting with a motor phenomena which can be accompanied with sensory and autonomic manifestation, impaied consciousness, aura (sensory, autonomic, or psychic symptoms), starting with a triggers, post-ictal drowsiness, tongue biting and urine and fecal incontinence.

Physical Examination

Common physical examination findings of epileptic seizure include Automatic behaviors, upward eye rolling, unconsciousness, drooling, cyanosis, post-ictal drowsiness, fever, tachycardia, hypertension, mydriasis, nystagmus, urine and fecal incontinence, disorientation to persons, place, and time, altered mental status, automatic behaviors (repetitive muscle movement), Muscle rigidity and hyper-reflexia.



Laboratory Findings

Laboratory findings consistent with the diagnosis of epilepsy include elevated creatine phosphokinase (CPK), elevated cortisol, elevated white blood cell count, elevated lactate dehydrogenase and elevated neuron-specific enolase.

Electroencephalogram

An ECG may be helpful in the diagnosis of epilepsy. Findings on an EEG suggestive of epilepsy include synchronous generalized spikes and waves in all leads in tonic-clonic seizures, spike and wave activity at a frequency of approximately 3 HZ in absence seizures, localized epileptic activity over the seizure focus in focal seizures with intact consciousness and temporal slow waves or spikes in focal seizures with impaired consciousness.

X-Ray

There are no x-ray findings associated with epilepsy.

Echocardiography/Ultrasound

In one case report, a 65-year-old woman presented with seizure. Echocardiography was performed and revealed a left atrium tumor.

CT Scan

CT Scan is mostly used in patients who are contraindicated for MRI or in the cases with skull fracture suspicious.

MRI

MRI may be helpful in the diagnosis of epilepsy. Findings on MRI suggestive epileptic seizure include mesial temporal sclerosis, sequelae of head injury, congenital anomalies, brain tumors, cysticercosis, vascular lesions, strokes, cerebral degeneration and neoplasms.

Other Imaging Findings

There are no other imaging findings associated with epilepsy.

Other Diagnostic Studies

Lumbar puncture may be helpful in differentiating epilepsy from infectious etiology of seizures.

Treatment

Medical Therapy

Supportive therapy for Guillain-Barre syndrome include respiratory assistance, Heart rate and blood pressure monitoring, prevention of thromboembolic complications by heparin, minimal sedation in intensive care units, pain control and early passive movements. Immunomodulating therapy for Guillain-Barre syndrome include plasma exchange, high dose immunoglobulin and Corticosteroids.

Surgery

Surgery is not the first-line treatment option for patients with epilepsy. Surgery is usually reserved for patients who their seizure continues to happen despite using maximum dosage of anti-seizure drugs.

Primary Prevention

Effective measures for the primary prevention of epilepsy include reducing the chance of possible epilepsy causes to happen (Head trauma, Hypoglycemia, Cerebral palsy, Electrolyte disturbances, fever, drug abuse and Vitamin deficiency) and reduce the seizure triggers (sleep deprivation, fever, light flashing, hyperventilation, alcohol, physical stress such as physical exercise or illness, psychological stress and depression).

Secondary Prevention

Effective measures for the secondary prevention of epilepsy include early diagnosis and effective treatment.


References

Template:WH Template:WS

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.,Vishnu Vardhan Serla M.B.B.S. [2]

Overview

The word epilepsy is derived from the Greek epilepsia, which in turn can be broken in to epi- (upon) and lepsis (to take hold of, or seizure). In the past, epilepsy was associated with religious experiences and even demonic possession. Claudius Galen was the first person who described epilepsy as a brain disease. Boerhaave was the first person who differentiate petit mal epilepsy, grand mal epilepsy and hysteria. Marshall Hall described reflex theory in which paroxysmal nervous discharges are responsible for epilepsy seizures. The very first evidence of epilepsy treatment goes back to 10,000 years ago when making holes in skull bones was done in order to treat epilepsy. In the past three decades anti-epileptic drugs are used widely for symptomatic control of epileptic patients.

Historical Perspective

Discovery

  • The word epilepsy is derived from the Greek epilepsia, which in turn can be broken in to epi- (upon) and lepsis (to take hold of, or seizure)[1]
  • In the past, epilepsy was associated with religious experiences and even demonic possession.
  • In ancient times, epilepsy was known as the “Sacred Disease” because people thought that epileptic seizures were a form of attack by demons, or that the visions experienced by persons with epilepsy were sent by the Gods.
  • Among animist Hmong families, for example, epilepsy was understood as an attack by an evil spirit, but the affected person could become revered as a shaman through these otherworldly experiences.[3]
  • However, in most cultures, persons with epilepsy have been stigmatized, shunned, or even imprisoned.
  • In the Salpêtrière, the birthplace of modern neurology, Jean-Martin Charcot found people with epilepsy side-by-side with the mentally retarded, those with chronic syphilis, and the criminally insane.
  • In Tanzania to this day, as with other parts of Africa, epilepsy is associated with possession by evil spirits, witchcraft, or poisoning and is believed by many to be contagious.[2]
  • In ancient Rome, epilepsy was known as the Morbus Comitialis (‘disease of the assembly hall’) and was seen as a curse from the gods.
  • Stigma continues to this day, in both the public and private spheres, but polls suggest it is generally decreasing with time, at least in the developed world.
  • Hippocrates remarked that epilepsy would cease to be considered divine the day it was understood.[3]
  • Claudius Galen was the first person who described epilepsy as a brain disease.

Landmark Events in the Development of Treatment Strategies

  • The very first evidence of epilepsy treatment goes back to 10,000 years ago when making holes in skull bones was done in order to treat epilepsy.[4]
  • In the past three decades anti-epileptic drugs are used widely for symptomatic control of epileptic patients.[5][6]

Famous Cases

The following are a few famous cases who are said to have had epilepsy:[7]

  • Pythagoras (582–500 BC)
  • Aristotle (384–322 BC)
  • Hannibal (Barca) (247–183 BC)
  • Alfred the Great (849–899)
  • Dante Alighieri (1265–1321)
  • Johanne la Pucelle (Joan of Arc) (1412–1431)
  • Leonardo da Vinci (1452–1519)
  • Michelangelo Buonarroti (1475–1564)
  • Armand-Jean du Plessis (Cardinal Richelieu) (1585–1642)
  • King Louis XIII of France (1601–1643)
  • Jean-Baptiste Poquelin-Molie´re (1622–1673)
  • Blaise Pascal (1623–1662)
  • Sir Isaac Newton (1642–1727)
  • William of Orange (1650–1702)
  • Jonathan Swift (1667–1745)
  • George Frideric Handel (1685–1759)
  • William Pitt, Earl of Chatham (1708–1778)
  • Samuel Johnson (1709–1784)
  • Jean Jacques Rousseau (1712–1778)
  • James Madison (1751–1836)
  • Ludwig von Beethoven (1770–1827)
  • Sir Walter Scott (1771–1832)
  • Niccolo Paganini (1784–1840)
  • George Gordon, Lord Byron (1788–1824)
  • Percy Bysshe Shelley (1792–1822)
  • Louis Hector Berlioz (1803–1869)
  • Edgar Allan Poe (1809–1849)
  • Alfred Lord Tennyson (1809–1892)
  • Robert Schumann (1810–1856)
  • Charles Dickens (1812–1870)
  • Søren Aabye Kierkegaard (1813–1855)
  • Hermann Ludwig Ferdinand Von Helmholtz (1821–1894)
  • Gustave Flaubert (1821–1880)
  • Leo Tolstoy (1828–1910)
  • Charles Lutwidge Dodgson, Lewis Carroll (1832–1898)
  • Alfred Nobel (1833–1896)
  • William Morris (1834–1896)
  • Algernon Charles Swinburne (1837–1909)
  • Henri-Rene´-Albert Guy de Maupassant (1850–1893)
  • Agatha (Miller) Christie (1890–1976)
  • Truman (Streckfus Persons) Capote (1924–1984)
  • Richard Burton (1925–1984)

Many studies demonstrated that there are doubts about diagnosis of epilepsy in these patients.

References

  1. Harper, Douglas (2001). “epilepsy”. Online Etymological Dictionary. Retrieved 2005-06-05.
  2. Morbus sacer in Africa: some religious aspects of epilepsy in traditional cultures. Jilek-Aall L. PMID: 10080524 Retrieved 8 October 2006.
  3. Hippocrates quotes
  4. 4.0 4.1 4.2 Hassell, Thomas (1981). Epilepsy and the oral manifestations of phenytoin therapy. Basel New York: Karger. ISBN 978-3-8055-1008-0.
  5. Löscher W, Schmidt D (April 2011). “Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma”. Epilepsia. 52 (4): 657–78. doi:10.1111/j.1528-1167.2011.03024.x. PMID 21426333.
  6. Schmidt D (June 2012). “Is antiepileptogenesis a realistic goal in clinical trials? Concerns and new horizons”. Epileptic Disord. 14 (2): 105–13. PMID 22977896.
  7. Hughes JR (March 2005). “Did all those famous people really have epilepsy?”. Epilepsy Behav. 6 (2): 115–39. doi:10.1016/j.yebeh.2004.11.011. PMID 15710295.

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Epilepsy may be classified according to type of onset into focal, generalized and unknown. Each of these groups can be further divided into motor and non-motor subgroups.

Classification

  • Epilepsy may be classified according to type of onset into:[1]


 
 
 
 
 
 
 
 
 
 
Type of onset
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Focal
 
secondary generalized
 
Generalized
 
 
 
 
 
 
 
Unknown
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Motor
 
Non-motor
 
Motor
 
Non-motor
 
Motor
 
Non-motor
 
Unclassified
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Automatisms
Atonic
Clonic
• Epileptic spasm
Hyperkinetic
Myoclonic
Tonic
 
Autonomic
• Behavior arrest
• Cognitive
• Emotional
Sensory
 
• Tonic-clonic
• Clonic
• Tonic
• Myoclonic
Myoclonic-tonic-clonic
Myoclonic-atonic
Atonia
• Epileptic spasm
 
• Typical
• Atypical
Myoclonic
Eyelid myocloni
 
Tonic-clonic
• Epileptic
Spasm
 
• Behavior arrest
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

References

  1. Fisher, Robert S.; Cross, J. Helen; D’Souza, Carol; French, Jacqueline A.; Haut, Sheryl R.; Higurashi, Norimichi; Hirsch, Edouard; Jansen, Floor E.; Lagae, Lieven; Moshé, Solomon L.; Peltola, Jukka; Roulet Perez, Eliane; Scheffer, Ingrid E.; Schulze-Bonhage, Andreas; Somerville, Ernest; Sperling, Michael; Yacubian, Elza Márcia; Zuberi, Sameer M. (2017). “Instruction manual for the ILAE 2017 operational classification of seizure types”. Epilepsia. 58 (4): 531–542. doi:10.1111/epi.13671. ISSN 0013-9580.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

It is understood that epileptic seizure is the result of uncontrolled unusual synchronized, localized or widely distributed neuronal electrical discharges. The underlying event in all types of seizures is the paroxysmal depolarization shift (PDS) which also causes the EEG changes. In a normal circumstance we have a refractory period after every action potential, but in PDS, the absence of refractory period causes a prolonged membrane depolarization. In order to cause a seizure, so many PDSs most happen in the same time. Any alternation in a synaptic characteristics such as amount of neurotransmitters, function of inhibitory neurons, function of excitatory neurons, synaptic structure and ion channels involved in neurotransmitter release and conduction of action potential can prone a person to epilepsy. In focal epilepsy, epileptiform activity starts in a specific area of brain. It can further spread and cause secondary generalized seizure. In generalized epilepsy seizures occur in both cerebral hemispheres simultaneously or spread so fast from one to another that in EEG, we can see bilateral epileptiform activity from the start.

Pathophysiology

Physiology

By Original by en:User:Chris 73, updated by en:User:Diberri, converted to SVG by tiZom – Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=2241513

Pathogenesis

Genetics

Gross Pathology

Microscopic Pathology

References

  1. Pollard, Thomas (2017). Cell biology. Philadelphia, PA: Elsevier. ISBN 9780323341264.
  2. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J (April 2005). “Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)”. Epilepsia. 46 (4): 470–2. doi:10.1111/j.0013-9580.2005.66104.x. PMID 15816939.
  3. MATSUMOTO H, AJMONEMARSAN C (April 1964). “CELLULAR MECHANISMS IN EXPERIMENTAL EPILEPTIC SEIZURES”. Science. 144 (3615): 193–4. PMID 14107481.
  4. Bragin A, Engel J, Wilson CL, Fried I, Mathern GW (February 1999). “Hippocampal and entorhinal cortex high-frequency oscillations (100–500 Hz) in human epileptic brain and in kainic acid–treated rats with chronic seizures”. Epilepsia. 40 (2): 127–37. PMID 9952257.
  5. Chang BS, Lowenstein DH (September 2003). “Epilepsy”. N. Engl. J. Med. 349 (13): 1257–66. doi:10.1056/NEJMra022308. PMID 14507951.
  6. Samuels, Martin (2017). Samuels’s Manual of neurologic therapeutics. Philadelphia: Wolters Kluwer Health. ISBN 9781496360311.
  7. Mattle, Heinrich (2017). Fundamentals of neurology : an illustrated guide. Stuttgart New York: Thieme. ISBN 9783131364524.
  8. 8.0 8.1 Samuels, Martin (2017). Samuels’s Manual of neurologic therapeutics. Philadelphia: Wolters Kluwer Health. ISBN 9781496360311.
  9. Miriam H. Meisler and Jennifer A. Kearney (2005). “Sodium channel mutations in epilepsy and other neurological disorders”. Journal of Clinical Investigation. 115 (8): 2010–2017. PMID 16075041 doi:10.1172/JCI25466.
  10. GOWERS, FirstName (2016). EPILEPSY AND OTHER CHRONIC CONVULSIVE DISEASES : their causes, symptoms, and treatment (classic… reprint. S.l: FORGOTTEN BOOKS. ISBN 1334720053.
  11. Blümcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, Bernasconi N, Bien CG, Cendes F, Coras R, Cross JH, Jacques TS, Kahane P, Mathern GW, Miyata H, Moshé SL, Oz B, Özkara Ç, Perucca E, Sisodiya S, Wiebe S, Spreafico R (July 2013). “International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods”. Epilepsia. 54 (7): 1315–29. doi:10.1111/epi.12220. PMID 23692496.

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D., Vishnu Vardhan Serla M.B.B.S. [2]

Overview

Common causes of epilepsy include Head trauma, Brain tumor, Brain hemorrhage, Encephalitis, Hypoglycemia, Hypoxic encephalopathy, Stroke, Cerebral palsy, Electrolyte disturbances, febrile seizures, Intoxication and uremia.

Causes

Life-threatening Causes

Life-threatening causes of epilepsy include:[1][2][3][4][5][6]

Common Causes

Common causes of epilepsy may include:[7][8][9][10][11][12]

less common causes

Less common causes of epilepsy include:[13]

Causes by Organ System

Cardiovascular Arrythmias, Cardiac failure, Carotid Sinus Syndrome, Hypertensive encephalopathy, Hypotension, Hypovolemia, Orthostatic hypotension, Stokes-Adams Syndrome, Syncope, Valvular heart disease
Chemical / poisoning Intoxication, Benzene hexachloride, Lead poisoning, Carbonmonoxide poisoning
Dermatologic Rud Syndrome
Drug Side Effect 4-aminopyridine, acyclovir, alcohol, almotriptan, alprazolam, aminophylline, amitriptyline, amoxapine , amphetamines , amphotericin B, aripiprazole, atomoxetine, atorvastatin, azathioprine, baclofen, benztropine , bromocriptine, bupivacaine, bupropion, buspirone, busulfan, cabergoline, caffeine, captopril, carisoprodol, carvedilol, cefepime, cefixime, cefotetan , ceftazidime, cefuroxime, cephalexin, chlorambucil, chloroquine, chlorpromazine, cilastatin/imipenem, ciprofloxacin, cisplatinum, citalopram , clomiphene , clomipramine, clonazepam, clorazepate, clozapine, cocaine, cyclobenzaprine, cyclobenzaprine , cyclophosphamide, cyclosporin, dantrolene , desipramine, dexmethylphenidate, dextroamphetamine, diazepam , dicyclomine, diphenhydramine, donepezil, doripenem, doxepin, doxorubicin, dronabinol, duloxetine, efavirenz, enfluraneketamine, entacapone, epoetin, escitalopram, estazolam, estrogen, eszopiclone, etoposide, fentanyl, fluoxetine, fluphenazine, flurazepam, fluvastatin, ganciclovir, gemifloxacin, Ginkgo biloba, glatiramer, haloperidol, hydroxyzine, imipenem, indomethacin, interferon beta-1a, interferon beta-1b, Isoniazid (INH), isotretinoin, ivermectin, ketorolac, levofloxacin, lidocaine, lindane, linezolid, lithium, lomefloxacin , lorazepam, loxapine, mefenamic acid, mefloquine, memantine, meperidine, mephobarbital, meropenem, methocarbamol, methotrexate, methylphenidate, metronidazole, mirtazapine, mitoxantrone, modafinil, molindone, montelukast, moxifloxacin, mycophenolate, nalidixic acid, nortriptyline , ofloxacin, olanzapine, ondansetron, oxybutynin, oxycodone, oxymorphone, oxytocin, paroxetine, pentazocine, phenobarbital, phenylpropanolamine, pimozide, pramipexole , prednisone, primidone , procaine , promethazine, propoxyphene , protriptyline, quetiapine , ramelteon, rasagiline, risperidone, rivastigmine, ropinirole, selegiline, sertraline, sibutramine, sildenafil, sodium oxydate, sumatriptan , tacrine, tacrolimus, tadalafil, temazepam, temozolomide, terbutaline, thalidomide, theophylline, thioridazine, thiothixene, ticlopidine, tinidazole, tizanidine, tolcapone, tolterodine, torsemide, tramadol, tranylcypromine , triazolam, trifluoperazine, trihexyphenidyl, Trovafloxacin mesylate, valacyclovir, valsartan, vardenafil, venlafaxine, vincristine, zaleplon, zanamivir, ziconotide, zidovudine, ziprasidone, ziprasidone, zolpidem
Ear Nose Throat Feigenbaum-Bergeron-Richardson syndrome, Wittwer sydnrome, Onychodystrophy — deafness, Ramsay Hunt Syndrome Type 2, Renier-Gabreels-Jasper syndrome
Endocrine Hyperglycemia, Hyperthyroidism, Hypoglycemia, Hypoparathyroidism, Hypothyroidism, Mental retardation — dysmorphism — hypogonadism — diabetes complex, X-linked Hypoparathyroidism , DEND syndrome, Feigenbaum-Bergeron-Richardson syndrome
Environmental Heat stroke
Gastroenterologic Liver disease — Retinitis pigmentosa — polyneuropathy — epilepsy complex
Genetic Angelman syndrome, Chromosome 15q triplication syndrome, Chromosome 15q13.3 microdeletion syndrome, Ring Chromosome 20, Chromosome 4, trisomy 4p, Cornelia de Lange syndrome 2, Deafness — congenital onychodystrophy – recessive form, DEND syndrome, Down’s Syndrome, Flynn-Aird syndrome, Lipoid proteinosis of Urbach and Wiethe, X-linked Mental retardation syndromic due to JARID1C mutation, X-linked Wittwer type Mental retardation, Mowat-Wilson syndrome, OFD syndrome type IX, Onychodystrophy — deafness, Renier-Gabreels-Jasper syndrome, Rud Syndrome, X-linked Spasticity — mental retardation — epilepsy, Von Hippel-Lindau Syndrome, X-linked Hypoparathyroidism , X-linked Lissencephaly – 2
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease

Bacteria: Tetany, Meningitis, Brain abscess, Encephalitis, Neurosyphilis

Virus: German measles, HIV, Meningitis, Ramsay Hunt Syndrome Type 2, Cytomegalovirus (CMV)

Parasites: Toxoplasmosis, Neurocysticercosis, Schistosomiasis, Trypanosomiasis, Cerebral malaria, Paragonimiasis, Ascariasis

Musculoskeletal / Ortho Craniodiaphyseal dysplasia, Fukuyama type muscular dystrophy, Gurrieri-Sammito-Bellussi syndrome, Epilepsy — microcephaly — skeletal dysplasia, Onychodystrophy — deafness
Neurologic Alzheimer’s Disease, Angelman syndrome, Anophthalmia — hypyothalamo-pituitary insufficiency, Astrocytoma, Autism, Benign familial infantile epilepsy, Brain abscess, Brain hemorrhage, Brain injury, Brain tumor, Cerebral Palsy, Concussion, Cortical dysplasia — focal epilepsy syndrome, Creutzfeldt-Jakob Disease, Diomedi-Bernardi-Placidi syndrome, DEND syndrome, Double cortex syndrome, Encephalitis, Familial Encephalopathy with neuroserpin inclusion bodies, Epilepsy — mental deterioration – Finnish type, Epilepsy — microcephaly — skeletal dysplasia, Epileptic encephalopathy – Lennox-Gastaut type, Flynn-Aird syndrome, Familial porencephaly, Focal cortical dysplasia, Huntington’s Chorea, Hypoxic encephalopathy, Idiopathic generalized, Intracranial hemorrhage and trauma, Kohlschutter-Tonz syndrome, Liver disease — retinitis pigmentosa — polyneuropathy — epilepsy complex, Meningioma, Microcephaly — mental retardation — spasticity — epilepsy complex, Microcephaly — pontocerebellar hypoplasia — dyskinesia complex, Microencephaly, Migraine, Movement disorders, Myoclonic progressive familial epilepsy, Myoclonus progressive epilepsy of Unverricht and Lundborg, Meningitis, Neurocysticercosis, X-linked Hamel type Neurodegenerative syndrome, Neurofibromatosis-1, Neurosyphilis, Perisylvian syndrome, Pick’s Disease, Pitt-Hopkins syndrome, Pontocerebellar hypoplasia with infantile spinal muscular atrophy, Presenile dementia, Reye’s Syndrome, Renier-Gabreels-Jasper syndrome, Rud Syndrome, Space occupying lesion of the brain, Spastic tetraplegic — cerebral palsy, Spinocerebellar ataxia 13, Stokes-Adams Syndrome, Stroke, Sturge-Weber Syndrome, Subependymal nodular heterotopia, Transient Ischemic Attack (TIA), Tuberous Sclerosis, X-linked Spasticity — mental retardation — epilepsy, X-linked Lissencephaly – 2, Wittwer sydnrome
Nutritional / Metabolic 2-Hydroxyglutaricaciduria, Acute intermittent porphyria, Carbohydrate deficiency glycoprotein syndrome type II, Gaucher’s Disease, Type 2 Hydroxyacyl-coa dehydrogenase deficiency, Pellagra, Phenylketonuria, Pyridoxine deficiency
Obstetric/Gynecologic Childbirth trauma, Eclampsia, Perinatal hypoxia or trauma
Oncologic Metastasis, Astrocytoma, Meningioma, Von Hippel-Lindau Syndrome
Opthalmologic Wittwer sydnrome, Anophthalmia — hypyothalamo-pituitary insufficiency, Liver disease — retinitis pigmentosa — polyneuropathy — epilepsy complex, Rud Syndrome
Overdose / Toxicity No underlying causes
Psychiatric Panic attack
Pulmonary Breath-holding spells (pediatric), Alveolar Hydatid Disease, Hyperventilation, Pediatric Apnea, Pitt-Hopkins syndrome, Hypoxic encephalopathy
Renal / Electrolyte Alkalosis, Chronic Renal Failure, Hypernatremia, Hypocalcemia, Hypomagnesemia, Hyponatremia, Uremia, Feigenbaum-Bergeron-Richardson syndrome
Rheum / Immune / Allergy Systemic lupus erythematosus, Polyarteritis nodosa
Sexual No underlying causes
Trauma Head trauma
Urologic No underlying causes
Dental No underlying causes
Miscellaneous Alcohol withdrawal, Battaglia Neri syndrome, Degenerative disease, Febrile Seizures, Fryns-Aftimos syndrome, McDowall syndrome, Mental retardation — epilepsy — bulbous nose, Mental retardation — epilepsy, Belgian type Mental retardation syndrome, Nicolaides-Baraitser syndrome, Night terrors, Photosensitive epilepsy, Schaefer-Stein-Oshman syndrome, Sleep disorders, Sleepwalking, Vasovagal syncope

Causes in Alphabetical Order









References

  1. Annegers JF, Coan SP (October 2000). “The risks of epilepsy after traumatic brain injury”. Seizure. 9 (7): 453–7. doi:10.1053/seiz.2000.0458. PMID 11034867.
  2. Englot DJ, Chang EF, Vecht CJ (2016). “Epilepsy and brain tumors”. Handb Clin Neurol. 134: 267–85. doi:10.1016/B978-0-12-802997-8.00016-5. PMC 4803433. PMID 26948360.
  3. Faught E, Peters D, Bartolucci A, Moore L, Miller PC (August 1989). “Seizures after primary intracerebral hemorrhage”. Neurology. 39 (8): 1089–93. PMID 2761703.
  4. Misra UK, Tan CT, Kalita J (August 2008). “Viral encephalitis and epilepsy”. Epilepsia. 49 Suppl 6: 13–8. doi:10.1111/j.1528-1167.2008.01751.x. PMID 18754956.
  5. Sloper JJ, Johnson P, Powell TP (September 1980). “Selective degeneration of interneurons in the motor cortex of infant monkeys following controlled hypoxia: a possible cause of epilepsy”. Brain Res. 198 (1): 204–9. PMID 7407585.
  6. Chung JM (May 2014). “Seizures in the acute stroke setting”. Neurol. Res. 36 (5): 403–6. doi:10.1179/1743132814Y.0000000352. PMID 24641717.
  7. Diaconu G, Burlea M, Grigore I, Frasin M (2003). “[Epilepsy in different types of cerebral palsy]”. Rev Med Chir Soc Med Nat Iasi (in Romanian). 107 (1): 136–9. PMID 14755984.
  8. Riggs JE (February 2002). “Neurologic manifestations of electrolyte disturbances”. Neurol Clin. 20 (1): 227–39, vii. PMID 11754308.
  9. Markand ON (2003). “Lennox-Gastaut syndrome (childhood epileptic encephalopathy)”. J Clin Neurophysiol. 20 (6): 426–41. PMID 14734932.
  10. Shinnar S, Glauser TA (January 2002). “Febrile seizures”. J. Child Neurol. 17 Suppl 1: S44–52. doi:10.1177/08830738020170010601. PMID 11918463.
  11. Cendes F, Andermann F, Carpenter S, Zatorre RJ, Cashman NR (January 1995). “Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotoxicity in humans”. Ann. Neurol. 37 (1): 123–6. doi:10.1002/ana.410370125. PMID 7818246.
  12. D’Hooge R, Pei YQ, Marescau B, De Deyn PP (October 1992). “Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice”. J. Neurol. Sci. 112 (1–2): 96–105. PMID 1469446.
  13. Keyser A, De Bruijn SF (1991). “Epileptic manifestations and vitamin B1 deficiency”. Eur. Neurol. 31 (3): 121–5. doi:10.1159/000116660. PMID 2044623.

Template:WH Template:WS

Differentiating Epilepsy from other Diseases

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Epilepsy must be differentiated from: Psychogenic nonepileptic attacks (PNEAs), syncope, hypoglycemia, panic attacks, acute dystonic reactions, hemifacial spasm, nonepileptic myoclonus, parasomnias, cataplexy, hypnic jerks, transient ischemic attacks, migraines and transient global amnesia.

Differentiating epilepsy from other Diseases

Epilepsy must be differentiated from:

  • Psychogenic nonepileptic attacks (PNEAs):
    • Psychogenic non epileptic attacks most commonly happens in young women and is the most common disease misdiagnosed with epilepsy.[1][2][3]
    • There are some features which can help us differentiate PNEAs from epilepsy:
      • These patients are resistance to anti-epileptic drugs.[4]
      • PNEAs rarely happens in sleep and mostly happens in the present of an audience.[5]
      • In physical examination of PNEAs patients we can observe histrionic features.[6]
      • Tongue biting, urine incontinence and postictal confusion are in favor of epilepsy.[6]
      • In PNEAs we have normal EEGs.[7]

A quick algorithm to differentiate epilepsy from other causes of altered mental status is demonstrated below:

 
 
 
 
 
 
 
 
 
Clinical presentation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loss of conscoiusness
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Transient?
• Rapid onset?
• Short duration?
• Spontaneous recovery?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Falls
 
Altered consciousnes
 
 
 
Yes
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Coma
 
Aborted SCD
 
Others
 
 
 
 
 
 
 
 
 
 
T-LOC
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-Traumatic
 
Traumatic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Syncope
 
 
Epileptic seizure
 
 
 
Psychogenic
 
 
Rare causes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Reflex syncope
Orthostatic hypotension
Cardiac syncope
 
 
• Tonic
• Clonic
• Tonic-clonic
• Atonic
 
 
 
• Pseudo-epileptic
• Pseudo-syncopal
 
 
 
 
 
 
 
 
 
 
 
 

Abbreviations: SCD: Sudden cardiac death;T-LOC: Transient-Loss of consciousness.

The above algorithm adopted from ESC guideline [23]

References

  1. Benbadis SR, O’Neill E, Tatum WO, Heriaud L (September 2004). “Outcome of prolonged video-EEG monitoring at a typical referral epilepsy center”. Epilepsia. 45 (9): 1150–3. doi:10.1111/j.0013-9580.2004.14504.x. PMID 15329081.
  2. Behrouz R, Heriaud L, Benbadis SR (May 2006). “Late-onset psychogenic nonepileptic seizures”. Epilepsy Behav. 8 (3): 649–50. doi:10.1016/j.yebeh.2006.02.003. PMID 16531122.
  3. Duncan R, Oto M, Martin E, Pelosi A (June 2006). “Late onset psychogenic nonepileptic attacks”. Neurology. 66 (11): 1644–7. doi:10.1212/01.wnl.0000223320.94812.7a. PMID 16769934.
  4. Benbadis SR (1999). “How many patients with pseudoseizures receive antiepileptic drugs prior to diagnosis?”. Eur. Neurol. 41 (2): 114–5. doi:10.1159/000008015. PMID 10023117.
  5. Benbadis SR, Lancman ME, King LM, Swanson SJ (July 1996). “Preictal pseudosleep: a new finding in psychogenic seizures”. Neurology. 47 (1): 63–7. PMID 8710126.
  6. 6.0 6.1 Benbadis SR, Wolgamuth BR, Goren H, Brener S, Fouad-Tarazi F (November 1995). “Value of tongue biting in the diagnosis of seizures”. Arch. Intern. Med. 155 (21): 2346–9. PMID 7487261.
  7. Davis BJ (2004). “Predicting nonepileptic seizures utilizing seizure frequency, EEG, and response to medication”. Eur. Neurol. 51 (3): 153–6. doi:10.1159/000077287. PMID 15017116.
  8. Aminoff MJ, Scheinman MM, Griffin JC, Herre JM (June 1988). “Electrocerebral accompaniments of syncope associated with malignant ventricular arrhythmias”. Ann. Intern. Med. 108 (6): 791–6. PMID 3369769.
  9. Sheldon RS, Koshman ML, Murphy WF (June 1998). “Electroencephalographic findings during presyncope and syncope induced by tilt table testing”. Can J Cardiol. 14 (6): 811–6. PMID 9676166.
  10. Sheldon R, Rose S, Ritchie D, Connolly SJ, Koshman ML, Lee MA, Frenneaux M, Fisher M, Murphy W (July 2002). “Historical criteria that distinguish syncope from seizures”. J. Am. Coll. Cardiol. 40 (1): 142–8. PMID 12103268.
  11. Merritt TC (May 2000). “Recognition and acute management of patients with panic attacks in the emergency department”. Emerg. Med. Clin. North Am. 18 (2): 289–300, ix. PMID 10767885.
  12. Vein AM, Djukova GM, Vorobieva OV (1994). “Is panic attack a mask of psychogenic seizures?–a comparative analysis of phenomenology of psychogenic seizures and panic attacks”. Funct. Neurol. 9 (3): 153–9. PMID 7988943.
  13. Biraben A, Taussig D, Thomas P, Even C, Vignal JP, Scarabin JM, Chauvel P (February 2001). “Fear as the main feature of epileptic seizures”. J. Neurol. Neurosurg. Psychiatry. 70 (2): 186–91. PMC 1737203. PMID 11160466.
  14. Dressler D, Benecke R (November 2005). “Diagnosis and management of acute movement disorders”. J. Neurol. 252 (11): 1299–306. doi:10.1007/s00415-005-0006-x. PMID 16208529.
  15. Colosimo C, Bologna M, Lamberti S, Avanzino L, Avanzino L, Marinelli L, Marinelli L, Fabbrini G, Abbruzzese G, Defazio G, Berardelli A (March 2006). “A comparative study of primary and secondary hemifacial spasm”. Arch. Neurol. 63 (3): 441–4. doi:10.1001/archneur.63.3.441. PMID 16533973.
  16. Derry CP, Davey M, Johns M, Kron K, Glencross D, Marini C, Scheffer IE, Berkovic SF (May 2006). “Distinguishing sleep disorders from seizures: diagnosing bumps in the night”. Arch. Neurol. 63 (5): 705–9. doi:10.1001/archneur.63.5.705. PMID 16682539.
  17. Iranzo A, Santamaría J, Rye DB, Valldeoriola F, Martí MJ, Muñoz E, Vilaseca I, Tolosa E (July 2005). “Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD”. Neurology. 65 (2): 247–52. doi:10.1212/01.wnl.0000168864.97813.e0. PMID 16043794.
  18. Guilleminault C, Gelb M (1995). “Clinical aspects and features of cataplexy”. Adv Neurol. 67: 65–77. PMID 8848983.
  19. Krahn LE, Boeve BF, Olson EJ, Herold DL, Silber MH (April 2000). “A standardized test for cataplexy”. Sleep Med. 1 (2): 125–130. PMID 10767653.
  20. Montagna P, Liguori R, Zucconi M, Sforza E, Lugaresi A, Cirignotta F, Lugaresi E (August 1988). “Physiological hypnic myoclonus”. Electroencephalogr Clin Neurophysiol. 70 (2): 172–6. PMID 2456194.
  21. Han SW, Kim SH, Kim JK, Park CH, Yun MJ, Heo JH (October 2004). “Hemodynamic changes in limb shaking TIA associated with anterior cerebral artery stenosis”. Neurology. 63 (8): 1519–21. PMID 15505181.
  22. Quinette P, Guillery-Girard B, Dayan J, de la Sayette V, Marquis S, Viader F, Desgranges B, Eustache F (July 2006). “What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases”. Brain. 129 (Pt 7): 1640–58. doi:10.1093/brain/awl105. PMID 16670178.
  23. Moya, A.; Sutton, R.; Ammirati, F.; Blanc, J.-J.; Brignole, M.; Dahm, J. B.; Deharo, J.-C.; Gajek, J.; Gjesdal, K.; Krahn, A.; Massin, M.; Pepi, M.; Pezawas, T.; Granell, R. R.; Sarasin, F.; Ungar, A.; van Dijk, J. G.; Walma, E. P.; Wieling, W.; Abe, H.; Benditt, D. G.; Decker, W. W.; Grubb, B. P.; Kaufmann, H.; Morillo, C.; Olshansky, B.; Parry, S. W.; Sheldon, R.; Shen, W. K.; Vahanian, A.; Auricchio, A.; Bax, J.; Ceconi, C.; Dean, V.; Filippatos, G.; Funck-Brentano, C.; Hobbs, R.; Kearney, P.; McDonagh, T.; McGregor, K.; Popescu, B. A.; Reiner, Z.; Sechtem, U.; Sirnes, P. A.; Tendera, M.; Vardas, P.; Widimsky, P.; Auricchio, A.; Acarturk, E.; Andreotti, F.; Asteggiano, R.; Bauersfeld, U.; Bellou, A.; Benetos, A.; Brandt, J.; Chung, M. K.; Cortelli, P.; Da Costa, A.; Extramiana, F.; Ferro, J.; Gorenek, B.; Hedman, A.; Hirsch, R.; Kaliska, G.; Kenny, R. A.; Kjeldsen, K. P.; Lampert, R.; Molgard, H.; Paju, R.; Puodziukynas, A.; Raviele, A.; Roman, P.; Scherer, M.; Schondorf, R.; Sicari, R.; Vanbrabant, P.; Wolpert, C.; Zamorano, J. L. (2009). “Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)”. European Heart Journal. 30 (21): 2631–2671. doi:10.1093/eurheartj/ehp298. ISSN 0195-668X.

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D. Vishnu Vardhan Serla M.B.B.S. [2]

Overview

Epilepsy’s approximate annual incidence rate is 40–70 per 100,000 in industrialized countries and 100–190 per 100,000 in resource-poor countries; socioeconomically deprived people are at higher risk. The prevalence of active epilepsy is roughly in the range 5–10 per 1000 people. Many studies have demonstrated that mortality rate is higher in people with epilepsy. The most common causes of death in these patients are trauma, pneumonia, suicide, status epilepticus and sudden unexpected death. Epilepsy is one of the most common of the serious neurological disorders. Genetic, congenital, and developmental conditions are mostly associated with it among younger patients; tumors are more likely over age 40; head trauma and central nervous system infections may occur at any age. There is no evidence of race differences in incidence and prevalence of epilepsy. It was demonstrated that nonsymptomatic epilepsy such as cryptogenic localization-related and idiopathic generalized epilepsy are more common in women while symptomatic localization-related epilepsy is more common in men.

Epidemiology and Demographics

Incidence

  • Epilepsy’s approximate annual incidence rate is 40–70 per 100,000 in industrialized countries and 100–190 per 100,000 in resource-poor countries; socioeconomically deprived people are at higher risk. In industrialized countries the incidence rate decreased in children but increased among the elderly during the three decades prior to 2003, for reasons not fully understood.[1]

Prevalence

  • The prevalence of active epilepsy is roughly in the range 5–10 per 1000 people. Up to 50 per 1000 people experience nonfebrile seizures at some point in life; epilepsy’s lifetime prevalence is relatively high because most patients either stop having seizures or (less commonly) die. [1]

Case-fatality rate/Mortality rate

Age

Race

    Gender

    • It was demonstrated that nonsymptomatic epilepsy such as cryptogenic localization-related and idiopathic generalized epilepsy are more common in women while symptomatic localization-related epilepsy is more common in men.[11]

    References

    1. 1.0 1.1 1.2 Sander JW (2003). “The epidemiology of epilepsy revisited”. Curr Opin Neurol. 16 (2): 165–70. PMID 12644744.
    2. Rafnsson V, Olafsson E, Hauser WA, Gudmundsson G (October 2001). “Cause-specific mortality in adults with unprovoked seizures. A population-based incidence cohort study”. Neuroepidemiology. 20 (4): 232–6. doi:10.1159/000054795. PMID 11684898.
    3. Camfield CS, Camfield PR, Veugelers PJ (June 2002). “Death in children with epilepsy: a population-based study”. Lancet. 359 (9321): 1891–5. doi:10.1016/S0140-6736(02)08779-2.
    4. Logroscino G, Hesdorffer DC, Cascino GD, Annegers JF, Bagiella E, Hauser WA (February 2002). “Long-term mortality after a first episode of status epilepticus”. Neurology. 58 (4): 537–41. PMID 11865129.
    5. Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC (April 2002). “Incidence and mortality of generalized convulsive status epilepticus in California”. Neurology. 58 (7): 1070–6. PMID 11940695.
    6. Sillanpää M, Shinnar S (September 2002). “Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland”. Ann. Neurol. 52 (3): 303–10. doi:10.1002/ana.10286. PMID 12205642.
    7. Nilsson L, Ahlbom A, Farahmand BY, Asberg M, Tomson T (June 2002). “Risk factors for suicide in epilepsy: a case control study”. Epilepsia. 43 (6): 644–51. PMID 12060025.
    8. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007-01-30). “How common are the ‘common’ neurologic disorders?”. Neurology. 68 (5): 326–37. PMID 17261678. Check date values in: |date= (help)
    9. Annegers JF, Dubinsky S, Coan SP, Newmark ME, Roht L (April 1999). “The incidence of epilepsy and unprovoked seizures in multiethnic, urban health maintenance organizations”. Epilepsia. 40 (4): 502–6. PMID 10219279.
    10. Benn EK, Hauser WA, Shih T, Leary L, Bagiella E, Dayan P, Green R, Andrews H, Thurman DJ, Hesdorffer DC (August 2008). “Estimating the incidence of first unprovoked seizure and newly diagnosed epilepsy in the low-income urban community of Northern Manhattan, New York City”. Epilepsia. 49 (8): 1431–9. doi:10.1111/j.1528-1167.2008.01564.x. PMID 18336560.
    11. Christensen J, Kjeldsen MJ, Andersen H, Friis ML, Sidenius P (June 2005). “Gender differences in epilepsy”. Epilepsia. 46 (6): 956–60. doi:10.1111/j.1528-1167.2005.51204.x. PMID 15946339.

    Template:WH Template:WS

    Risk Factors

    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.,

    Overview

    Common triggers of seizure include: Sleep deprivation, fever, light flashing, hyperventilation, alcohol, physical stress such as physical exercise or illness, psychological stress, depression.

    Risk Factors

    Common risk factors of seizure include:[1][2][3]

    References

    1. Løyning Y (August 1993). “[Seizures and traffic risks]”. Tidsskr. Nor. Laegeforen. (in Norwegian). 113 (18): 2231. PMID 8362382.
    2. Thapar A, Kerr M, Harold G (January 2009). “Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures”. Epilepsy Behav. 14 (1): 134–40. doi:10.1016/j.yebeh.2008.09.004. PMID 18824131.
    3. LEVIN M (February 1950). “The pathogenesis of narcoleptic and epileptic seizures occurring under acute emotional stress”. J. Nerv. Ment. Dis. 111 (2): 101–8. PMID 15409992.

    Template:WH Template:WS

    Screening


    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

    Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

    Overview

    There is insufficient evidence to recommend routine screening for epilepsy.

    Screening

    There is insufficient evidence to recommend routine screening for epilepsy.

    References

    Template:WH Template:WS

    Natural History, Complications and Prognosis

    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

    Overview

    If left untreated, 23% to 71% of patients with a single unprovoked seizure may experience it again within 2 years. After the second unprovoked seizure, the chance of having another seizure increase to 73%. Recurrent seizures with no underlying illness emphasis on epilepsy diagnosis. Common complications of epilepsy include: Status epilepticus, sudden unexpected death, submersion Injury, dental injury, burns, fractures, head injury, soft tissue injury and motor vehicle accidents.

    Natural History, Complications, and Prognosis

    Natural History

    • If left untreated, 23% to 71% of patients with a single unprovoked seizure may experience it again within 2 years.
    • After the second unprovoked seizure, the chance of having another seizure increase to 73%.
    • Recurrent seizures with no underlying illness emphasis on epilepsy diagnosis.
    • In contrast to adolescent onset epilepsy syndromes most of the childhood onset epilepsy such as benign childhood epilepsy with centrotemporal spikes will go to remission.
    • There is no evidence demonstrating the effect of medical therapy on natural history of epilepsy.[1]

    Complications

    References

    1. Samuels, Martin (2017). Samuels’s Manual of neurologic therapeutics. Philadelphia: Wolters Kluwer Health. ISBN 9781496360311.
    2. Mattle, Heinrich (2017). Fundamentals of neurology : an illustrated guide. Stuttgart New York: Thieme. ISBN 9783131364524.
    3. Samuels, Martin (2017). Samuels’s Manual of neurologic therapeutics. Philadelphia: Wolters Kluwer Health. ISBN 9781496360311.
    4. Buck D, Baker GA, Jacoby A, Smith DF, Chadwick DW (April 1997). “Patients’ experiences of injury as a result of epilepsy”. Epilepsia. 38 (4): 439–44. PMID 9118849.
    5. van den Broek M, Beghi E (January 2004). “Morbidity in patients with epilepsy: type and complications: a European cohort study”. Epilepsia. 45 (1): 71–6. PMID 14692910.
    6. Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane E (April 2003). “Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs”. Epilepsy Behav. 4 (2): 169–74. PMID 12697142.
    7. Beghi E, Cornaggia C (September 2002). “Morbidity and accidents in patients with epilepsy: results of a European cohort study”. Epilepsia. 43 (9): 1076–83. PMID 12199734.
    8. Hansotia P, Broste SK (1993). “Epilepsy and traffic safety”. Epilepsia. 34 (5): 852–8. PMID 8404737.
    9. Verrier, Richard L.; Pang, Trudy D.; Nearing, Bruce D.; Schachter, Steven C. (2020). “The Epileptic Heart: Concept and clinical evidence”. Epilepsy & Behavior. 105: 106946. doi:10.1016/j.yebeh.2020.106946. ISSN 1525-5050.
    Diagnosis

    Diagnosis

    Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | EEG | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

    Treatment

    Treatment

    Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

    Case Studies

    Case Studies

    Case #1

    Related Chapters
    External Links

    Professional Resources

    Lists of Organizations

    Many organisations provide regional support for those with epilepsy, their families and professionals in the field. Lists of such groups can be found at:


    Template:Diseases of the nervous system


    Template:WikiDoc Sources

    Looking for the patient version?

    Back to the patient-friendly article

    © 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH